QuantLogix ← CI scorecard
📅 CI Earnings Preview
The Cigna Group
Next report (est.)
01/05/2027
Countdown
115 days
EPS growth YoY
+10.2%
Revenue growth YoY
+6.7%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
07/30/2026 ±2.6% -3.0% under-priced
10/30/2025 ±2.5% -17.4% under-priced
07/31/2025 ±3.0% -10.2% under-priced
05/02/2025 ±1.9% -0.1% over-priced
10/31/2024 ±2.0% +0.6% over-priced
08/01/2024 ±2.0% -4.6% under-priced
05/02/2024 ±1.4% -3.5% under-priced
11/02/2023 ±1.5% +3.1% under-priced
Across these reports, options implied an average ±2.1% move vs an actual average of 5.3% — the stock stayed inside the implied band 25% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $6.29 $71.7B $1.9B
Q1 FY2026 $6.26 $68.5B $1.9B
Q4 FY2025 $4.66 $72.5B $1.3B
Q3 FY2025 $6.98 $69.7B $2.0B
Analyst posture
Buy / Strong Buy
26
Hold
8
Sell
0
Downward revisions — 35 net (vs 38 prior)
Live 5-factor engine read: Buy · 65/100 Full scorecard →
🤖 Pro runs a 10-agent AI debate on CI before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

The Cigna Group (CI) reports in 115 days, with the next report estimated for 01/05/2027. Across the last 8 reports, options priced an average ±2.1% earnings move while the stock actually moved 5.3% on average — the market has tended to under-price CI's earnings risk. Fundamentals into the print: EPS up 10.2% year-over-year, revenue up 6.7%. QuantLogix's live 5-factor engine currently reads CI as a buy at 65/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →